Brevital Sodium 500 mg/1
methohexital sodium · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Par Health USA, LLC
No Recall History
Plain English
Brevital Sodium is a injection, powder, lyophilized, for solution containing methohexital sodium at 500 mg/1, taken intramuscular. Manufactured by Par Health USA, LLC.
Key Facts
- Brand Name
- Brevital Sodium
- Generic Name
- methohexital sodium
- NDC Code (Product)
42023-105- Manufacturer
- Par Health USA, LLC
- Strength
- 500 mg/1
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAMUSCULAR, INTRAVENOUS, RECTAL
- Marketing Status
- DEA Schedule
- Schedule IV (Controlled)
- Application #
- NDA011559
- Marketing Start
- 11/01/2007
Recall History
No Recall HistoryFrequently Asked Questions
What is Brevital Sodium used for?
Brevital Sodium contains methohexital sodium. It is a injection, powder, lyophilized, for solution taken intramuscular. Consult your doctor for specific uses.
Is Brevital Sodium a controlled substance?
Yes, Brevital Sodium is classified as CIV under the DEA Controlled Substances Act.
What is the generic name for Brevital Sodium?
The generic name for Brevital Sodium is methohexital sodium. There are 2 other brand versions of methohexital sodium.
What is the NDC code for Brevital Sodium 500 mg/1?
The NDC (National Drug Code) for Brevital Sodium 500 mg/1 is 42023-105, listed by Par Health USA, LLC.